Specifically, the decrease in SIRT1 levels, inhibition of its activity, or generation of mutations that lower its activity have been linked to intestinal inflammation and colitis in human and rodent models (Caruso et al., 2014; Melhem et al., 2016; Wellman et al., 2017). This evidence concerns the gene SIRT1 and colitis.